PDK2 and neoplasm: The impact of miR-422a and PDK2 on ROS levels could be partially abrogated via modulation of de novo lipogenesis, emphasizing the crucial effects of reprogramming metabolism, not only aerobic glycolysis but also other metabolic pathways, including lipogenesis, in tumorigenesis and tumor progression.